We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Jounce Therapeutics Inc | NASDAQ:JNCE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.88 | 2.00 | 1.79 | 0 | 01:00:00 |
“On behalf of the whole Jounce team, I want to take the opportunity to congratulate Jim on this historic recognition and honor. Since our founding, Jounce has benefited tremendously from his leadership, expertise and dedication to cancer immunotherapy and this award is a testament to all that he has accomplished,” said Richard Murray, Ph.D., chief executive officer and president of Jounce Therapeutics. “Jim played a fundamental role in ushering in the era of cancer immunotherapy, including his contributions to the understanding of the basic science of CTLA-4. Additionally, the identification of ICOS as a therapeutic approach in immuno-oncology led to the discovery and development of Jounce’s lead product candidate, JTX-2011.”
Additional information regarding Dr. James P. Allison’s biography and award can be found here.
About Jounce TherapeuticsJounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently conducting the Phase 1/2 ICONIC trial. For more information, please visit www.jouncetx.com.
Investor Contact: Komal Joshi Jounce Therapeutics, Inc. (857) 320-2523 kjoshi@jouncetx.com
Media Contact: Gina Nugent The Yates Network (617) 460-3579 gina@theyatesnetwork.com
1 Year Jounce Therapeutics Chart |
1 Month Jounce Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions